Innovative MedTech (IMTH) 10-Q 1 Feb 21 2014 Q1 Quarterly report Financial data

Cover

Cover	3 Months Ended
	Jan. 31, 2014shares
Cover [Abstract]
Entity Registrant Name	Fresh Harvest Products, Inc.
Entity Central Index Key	0001331612
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--10-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	No
Document Period End Date	Jan. 31, 2014
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2014
Entity Common Stock Shares Outstanding	1,635,610,445
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Jan. 31, 2014	Oct. 31, 2013
ASSETS
Total assets	$ 0	$ 0
Current liabilities
Accounts payable and accrued expenses	1,443,409	1,384,629
Accrued interest	266,158	248,687
Notes payable, related party, current	32,312	32,312
Notes payable, current, net of debt discount	599,589	565,733
Derivative liability	515,733	435,515
Total current liabilities	2,857,201	2,666,876
Total liabilities	2,857,201	2,666,876
Commitments and contingencies (Note 10)	0	0
Stockholders' deficit
Preferred stock, $.0001 par value, 5,000,000 shares authorized, 5,000,000 issued and outstanding	500	500
Common stock, $.0001 par value, 2,000,000,000 authorized shares, 1,635,610,445 shares issued and outstanding	163,562	163,562
Additional paid in capital	7,054,106	7,054,106
Accumulated deficit	(10,075,369)	(9,885,044)
Total stockholders' deficit	(2,857,201)	(2,666,876)
Total liabilities and stockholders' deficit	$ 0	$ 0

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - $ / shares	Jan. 31, 2014	Oct. 31, 2013
Stockholders' deficit
Preferred stock, shares par value	$ .0001	$ .0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	5,000,000	5,000,000
Preferred stock, shares outstanding	5,000,000	5,000,000
Common stock, shares par value	$ .0001	$ .0001
Common stock, shares authorized	2,000,000,000	2,000,000,000
Common stock, shares issued	1,635,610,445	1,635,610,445
Common stock, shares outstanding	1,635,610,445	1,635,610,445

STATEMENTS OF OPERATIONS (Unaud

STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Jan. 31, 2014	Jan. 31, 2013
STATEMENTS OF OPERATIONS (Unaudited)
Revenue	$ 0	$ 0
Cost of goods sold	0	0
Gross profit	0	0
Operating expenses
Sales and marketing	50,000	50,000
Salaries and wages	36,000	36,000
General and administrative	21,281	22,339
Legal and professional fees	1,500	100
Total operating expenses	108,781	108,439
Loss from operations	(108,781)	(108,439)
Other income (expense)
Change in fair value of derivatives	(30,218)	(61,697)
Interest expense	(51,326)	(27,302)
Total other income (expenses)	(81,544)	(88,999)
Loss before provision for income taxes	(190,325)	(197,438)
Provision for income taxes	0	0
Net loss	$ (190,325)	$ (197,438)
Basic and dilutive loss per share	$ 0	$ 0
Weighted average common shares outstanding - basic and dilutive	1,635,610,445	1,635,610,445

STATEMENTS OF CASH FLOWS (Unaud

STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Jan. 31, 2014	Jan. 31, 2013
Cash flows from operating activities:
Net loss	$ (190,325)	$ (197,438)
Adjustments to reconcile net loss to net cash (used in) operating activities:
Amortization of debt discount	33,856	9,317
Change in fair value of derivatives	80,218	61,697
Changes in operating assets and liabilities:
Accounts payable and accrued expenses	58,780	108,439
Accrued interest	17,471	17,984
Cash (used in) operating activities	0	0
Net (decrease) increase in cash	0	0
Cash, beginning of period	0	0
Cash, end of period	0	0
Supplemental disclosure of cash flow information:
Taxes paid	0	0
Interest paid	0	0
Non-cash financing activities:	0	0
Convertible notes payable issued for accounts payable	$ 50,000	$ 0

GENERAL ORGANIZATION AND BUSINE

GENERAL ORGANIZATION AND BUSINESS	3 Months Ended
	Jan. 31, 2014
GENERAL ORGANIZATION AND BUSINESS
NOTE 1. GENERAL ORGANIZATION AND BUSINESS	Fresh Harvest Products, Inc., a New Jersey corporation (the “Company”), is engaged in the software and mobile application development and video production businesses. The Company previously operated as a natural and organic food products company before management decided to transition the Company’s line of business to capitalize on its relationships within the rapidly growing Software-as-a-Service (SaaS), enterprise software and mobile application markets. During October 2012, the Company began integrating a digital plan and strategy which will shift the Company’s focus on expanding the online network and community, as well as an expansion of online services, with a focus on developing various SaaS models in the health, wellness, fitness, lifestyles of health and sustainability (LOHAS) and healthcare industries. The Company expects to develop, license and acquire software applications that will generate revenue through subscription fees, in-app upgrades, purchases and advertising. The Company is currently working on several software applications including a calorie calculator and food comparison software solution so that consumers can be informed and compare what foods they are eating and be able to accurately calculate their daily calories per item, as well as compare foods with each other to learn and understand what the healthier options are. The Company is actively seeking strategic partners and acquisition targets in order to grow and expand.

LIQUIDITY, CAPITAL RESOURCES AN

LIQUIDITY, CAPITAL RESOURCES AND GOING CONCERN	3 Months Ended
	Jan. 31, 2014
LIQUIDITY, CAPITAL RESOURCES AND GOING CONCERN
NOTE 2. LIQUIDITY, CAPITAL RESOURCES AND GOING CONCERN	The accompanying financial statements have been prepared on a going-concern basis, which contemplates the continuation of operations, realization of assets and liquidation of liabilities in the ordinary course of business. For the quarters ended January 31, 2014 and 2013, the Company reported a net loss of $190,325 and $197,438, respectively. As of January 31, 2014, the Company maintained total assets of $0, total liabilities including long-term debt of $2,857,201 along with an accumulated deficit of $10,075,369. The Company believes that additional capital will be required to fund operations through the year ended October 31, 2014 and beyond, as it attempts to generate increasing revenue, and develop new products. The Company intends to attempt to raise capital through additional equity offerings and debt obligations. There can be no assurance that the Company will be successful in obtaining financing at the level needed or on terms acceptable to the Company. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying quarterly financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company’s insolvent financial condition also may create a risk that the Company may be forced to file for protection under applicable bankruptcy laws or state insolvency statutes. The Company also may face the risk that a receiver may be appointed. The Company may face additional risks resulting from our current financial condition. For these and other reasons, our management recognizes the adverse difficulties and continuing severe challenges we face. Apart from the limited funds that the Company has received there can be no assurance that the Company will receive any financing or funding from any source or if any financing should be obtained, that existing shareholders will not incur substantial, immediate, and permanent dilution of their existing investment. The Company’s operations are subject to certain additional risks and uncertainties including, among others, dependence on outside suppliers and manufacturers, competition, dependence on its exclusive license and relationship with the licensor, uncertainties regarding patents and proprietary rights, dependence on key personnel, and other business risks. In addition, there is no assurance, assuming the Company is successful in raising additional capital that the Company will be successful in achieving profitability or positive cash flow.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Jan. 31, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Basis of Presentation The accompanying financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and reflect all adjustments, consisting of normal recurring adjustments, which management believes are necessary to fairly present the financial position, results of operations and cash flows of the Company as of and for the quarters ended January 31, 2014 and 2013. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported revenues and expenses during the reporting periods. Because of the use of estimates inherent in the financial reporting process, actual results may differ significantly from those estimates. Cash and Cash Equivalents The Company maintains cash balances in a non-interest bearing account that currently does not exceed federally insured limits. For the purpose of the statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents. There were no cash equivalents as of January 31, 2014 and October 31, 2013. Net Loss Per Share Calculation Basic net loss per common share ("EPS") is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued. Revenue Recognition and Sales Incentives Sales will be recognized when an online or mobile transaction is processed, which occurs when a user of one of the Company’s software products purchases the products online or in an app. Sales are reported net of sales incentives, which could include discounts and promotions. Income Taxes The provision for income taxes is the total of the current taxes payable and the net of the change in the deferred income taxes. Provision is made for the deferred income taxes where differences exist between the period in which transactions affect current taxable income and the period in which they enter into the determination of net income in the financial statements. Fair value of financial instruments Fresh Harvest’s financial instruments include cash and cash equivalents, accounts payable, accrued liabilities, and debt. The carrying value of these financial instruments is considered to be representative of their fair value due to the short maturity of these instruments. The carrying amount of the debt approximates fair value, because the interest rates on these instruments approximate the interest rate on debt with similar terms available to the Company. Fresh Harvest’s derivative liabilities were adjusted to fair market value at the end of each reporting period, using Level 3 inputs. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows: Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities. The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts payable, accrued expenses and interest, certain notes payable and notes payable – due to related parties, approximate their fair values because of the short maturity of these instruments. The Company accounts for its derivative liabilities, at fair value, on a recurring basis under Level 3 (See Note 6). Embedded Conversion Features The Company evaluates embedded conversion features within convertible debt under Accounting Standards Codification (“ASC”) 815 “Derivatives and Hedging” to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 “Debt with Conversion and Other Options” for consideration of any beneficial feature. Derivative financial instruments When the Company issues debt that contains a conversion feature, it first evaluates whether the conversion feature meets the requirements to be treated as a derivative: a) one or more underlying, typically the price of the Company's stock; b) one or more notional amounts or payment provisions or both, generally the number of shares upon conversion; c) no initial net investment, which typically excludes the amount borrowed; and d) net settlement provisions, which in the case of convertible debt generally means the stock received upon conversion can be readily sold for cash. There are certain scope exceptions from derivative treatment, but these typically exclude conversion features that provide for a variable number of shares. If the conversion feature within convertible debt meet the requirements to be treated as a derivative, Fresh Harvest estimates the fair value of the derivative liability using the Monte Carlo Simulation Model upon the date of issuance. If the fair value of the derivative liability is higher than the face value of the convertible debt, the excess is immediately recognized as interest expense. Otherwise, the fair value of the derivative liability is recorded as a liability with an offsetting amount recorded as a debt discount, which offsets the carrying amount of the debt. The derivative liability is revalued at the end of each reporting period and any change in fair value is recorded as a change in fair value in the statements of operations. The debt discount is amortized through interest expense over the life of the debt. Derivative instrument liabilities and the host debt agreement are classified on the balance sheets as current or non-current based on whether settlement of the derivative instrument could be required within twelve months of the balance sheet date. The accounting treatment of derivative financial instruments requires that the Company record the embedded conversion option and warrants at their fair values as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded as non-operating, non-cash income or expense for each reporting period at each balance sheet date. The Company reassesses the classification of its derivative instruments at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. As a result of entering into warrant agreements, for which such instruments contained a variable conversion feature with no floor, the Company has adopted a sequencing policy in accordance with ASC 815-40-35-12 “Derivatives and Hedging” (provides comprehensive guidance on derivative and hedging transactions) whereby all future instruments may be classified as a derivative liability with the exception of instruments related to share-based compensation issued to employees or directors. Debt Issue Costs and Debt Discount The Company may record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash, or equity (such as warrants). These costs are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed. Share-based compensation The Company accounts for common stock issued to employees, directors, and consultants in accordance with the provisions of the Accounting Standards Codification (ASC) 718 Stock Based Compensation Recently Issued Accounting Pronouncements As of and for the fiscal quarter ended January 31, 2014, the Company does not expect any of the recently issued accounting pronouncements to have a material impact on its financial condition or results of operations. Subsequent Events In accordance with ASC 855, Subsequent Events, the Company evaluated subsequent events through the date of this report; the date the financial statements were available for issue.

NOTES PAYABLE - RELATED PARTIES

NOTES PAYABLE - RELATED PARTIES	3 Months Ended
	Jan. 31, 2014
NOTES PAYABLE - RELATED PARTIES
NOTE 4. NOTES PAYABLE - RELATED PARTIES	As of January 31, 2014 and October 31, 2013 the Company had $32,312 in outstanding notes payable to related parties. As of January 31, 2014 and October 31, 2013, the Company had $4,119 and $3,231, respectively, in outstanding interest to related parties. The outstanding notes payable have one-year terms and 10% interest rates. The principal amount of the notes and accrued and unpaid interest is convertible into common shares of the Company upon the due date at $0.0001 per share, subject to adjustments.

NOTES PAYABLE

NOTES PAYABLE	3 Months Ended
	Jan. 31, 2014
NOTES PAYABLE
NOTE 5. NOTES PAYABLE	The Company entered into one note payable during the quarter ended January 31, 2014. As of January 31, 2014 and October 31, 2013, the notes payable are as follows: Date of Note Issuance Original Principal Balance Maturity Date Interest Rate % Conversion Rate Principal Balance 1/31/14 Principal Balance 10/31/13 11/1/13 $ 50,000 11/1/14 10 % lesser $0.0003 or 50% discount to market $ 50,000 $ - 2/1/13 50,000 2/1/14 10 % lesser $0.0015 or 50% discount to market 50,000 50,000 10/31/12 104,278 10/31/13 10 % lesser $0.0015 or 50% discount to market 104,278 104,278 3/16/12 50,000 9/16/12 10 % $ 0.00200 60,000 60,000 2/14/12 14,900 2/14/13 10 % $ 0.00100 24,900 24,900 2/10/12 25,000 8/10/12 10 % $ 0.00119 25,000 25,000 1/26/12 40,000 7/26/12 10 % $ 0.00113 8,000 8,000 1/26/12 65,595 7/26/12 10 % $ 0.00113 27,595 27,595 10/18/11 1,900 10/18/11 8 % no written agreement 6,900 6,900 10/11/11 2,500 4/11/12 12 % $ 0.00390 2,500 2,500 8/25/11 108,101 2/25/12 10 % $ 0.01000 2,631 2,631 10/3/10 20,000 10/3/12 10 % lesser $0.01 or 20% discount to market 20,000 20,000 10/31/09 4,000 10/31/10 8 % no written agreement 4,000 4,000 8/31/09 5,000 8/31/12 12 % lesser $0.01 or 20% discount to market 5,000 5,000 8/26/09 20,000 8/26/12 12 % lesser $0.01 or 20% discount to market 20,000 20,000 8/25/09 20,000 8/25/12 12 % lesser $0.01 or 20% discount to market 20,000 20,000 2/26/07 30,000 2/26/09 12 % lesser $0.50 or 35% discount to market 30,000 30,000 4/17/07 20,000 4/17/09 10 % lesser $0.45 or 35% discount to market 20,000 20,000 6/14/07 15,000 6/15/09 10 % lesser $0.50 or 25% discount to market 15,000 15,000 1/29/07 15,000 1/29/09 10 % $ 0.95000 15,000 15,000 4/17/07 15,000 4/17/09 10 % lesser $0.45 or 35% discount to market 15,000 15,000 12/23/06 18,000 12/23/08 10 % $ 0.95000 18,000 18,000 11/30/06 50,000 11/30/08 10 % $ 0.85000 50,000 50,000 9/16/06 100,000 9/9/08 12 % 35% discount to market 38,000 38,000 10/1/05 15,000 4/1/07 10 % $ 0.50000 15,000 15,000 Total $ 646,804 $ 596,804 Debt Discount (47,215 ) (31,071 ) Total $ 599,589 $ 565,733 The Company currently has a total of twenty-three convertible promissory notes that are in default and we may be subject to legal proceedings or lawsuits from any number of those convertible noteholders.

DERIVATIVE LIABILITY

DERIVATIVE LIABILITY	3 Months Ended
	Jan. 31, 2014
DERIVATIVE LIABILITY
NOTE 6. DERIVATIVE LIABILITY	The following tables summarize the components of the Company’s derivative liabilities and linked common shares as of January 31, 2014 and October 31, 2013 and the amounts that were reflected in income related to derivatives for the quarter and year then ended: January 31, 2014 Indexed Fair The financings giving rise to derivative financial instruments Shares Values Compound embedded derivative 2,978,951,043 $ (515,733 ) October 31, 2013 Indexed Fair The financings giving rise to derivative financial instruments Shares Values Compound embedded derivative 2,549,713,618 $ (435,515 ) The following tables summarizes the effects on the Company’s gain (loss) associated with changes in the fair values of the derivative financial instruments by type of financing for the three months ended January 31, 2014 and 2013: The financings giving rise to derivative financial instruments and the income effects: Three Months Ended January 31, 2014 January 31, 2013 Compound embedded derivative $ (21,551 ) $ 61,697 Day one derivative loss (8,667 ) - Total derivative gain (loss) $ (30,218 ) $ 61,697 The Company’s Convertible Notes gave rise to derivative financial instruments. The Notes embodied certain terms and conditions that were not clearly and closely related to the host debt agreement in terms of economic risks and characteristics. These terms and features consist of the embedded conversion option. Current accounting principles that are provided in ASC 815 - Derivatives and Hedging Significant inputs and results arising from the Monte Carlo Simulations process are as follows for the compound embedded derivative that has been bifurcated from the Convertible Notes and classified in liabilities: January 31, 2014 January 31, 2013 Quoted market price on valuation date $ 0.0003 $ 0.0002 Contractual conversion rate $ 0.00011 - $0.00023 $ 0.0009 - $0.00015 Range of effective contractual conversion rates -- -- Contractual term to maturity 0.25 Years 1.00 Year Market volatility: Volatility 138.28% - 238.13 % 138.28% - 238.13 % Contractual interest rate 5% - 12 % 5% - 12 % The following table reflects the issuances of compound embedded derivatives and changes in fair value inputs and assumptions related to the compound embedded derivatives during the quarter ended January 31, 2014 and the year ended October 31, 2013. January 31, 2014 October 31, 2013 Beginning balance $ 435,515 $ 334,526 Issuances: Convertible Note Financing 50,000 50,000 Changes in fair value inputs and assumptions reflected in income 30,218 50,989 Ending balance $ 515,733 $ 435,515 The fair value of the compound embedded derivative is significantly influenced by the Company’s trading market price, the price volatility in trading and the interest components of the Monte Carlo Simulation technique.

STOCKHOLDERS EQUITY

STOCKHOLDERS EQUITY	3 Months Ended
	Jan. 31, 2014
STOCKHOLDERS EQUITY
NOTE 7. STOCKHOLDERS' EQUITY	Series A Preferred Stock Certificate of Designations On February 23, 2011, the Company filed a Certificate of Designations of Series A Convertible Preferred Stock (the “ Certificate of Designations Series A Preferred Stock Number 5,000,000 shares of the Company’s Preferred Stock are designated as shares of Series A Convertible Preferred Stock. Dividends Any dividends (other than dividends on common stock payable solely in common stock or dividends on the Series A Preferred Stock payable solely in Series A Preferred Stock) declared or paid in any fiscal year will be declared or paid among the holders of the Series A Preferred Stock and common stock then outstanding in proportion to the greatest whole number of shares of common stock which would be held by each such holder if all shares of Series A Preferred Stock were converted into shares of common stock pursuant to the terms of the Certificate of Designations. The Company’s Board of Directors is under no obligation to declare dividends on the Series A Preferred Stock. Conversion Each share of Series A Preferred Stock is generally convertible into 100 shares of the Company’s common stock (the “ Conversion Rate Liquidation In the event of any liquidation, dissolution or winding up of the Company, the assets of the Company legally available for distribution by the Company would be distributed with equal priority and pro rata among the holders of the Series A Preferred Stock and common stock in proportion to the number of shares of common stock held by them, with the shares of Series A Preferred Stock being treated for this purpose as if they had been converted to shares of common stock at the then applicable Conversion Rate. Voting On any matter presented to the stockholders of the Company for their action or consideration at any meeting of stockholders of the Company (or by written consent of stockholders in lieu of meeting), each holder of outstanding shares of Series A Preferred Stock would be entitled to cast the number of votes equal to the number of whole shares of common stock into which the shares of Series A Preferred Stock held by such holder are convertible as of the record date for determining stockholders entitled to vote on such matter. Except as provided by law or by the other provisions of the Company’s Certificate of Incorporation, holders of Series A Preferred Stock vote together with the holders of common stock as a single class.

PROVISION FOR CORPORATE INCOME

PROVISION FOR CORPORATE INCOME TAXES	3 Months Ended
	Jan. 31, 2014
PROVISION FOR CORPORATE INCOME TAXES
NOTE 8. PROVISION FOR CORPORATE INCOME TAXES	The Company provides for income taxes by the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. This also requires the reduction of deferred tax assets by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The valuation allowance at January 31, 2014 was $2,850,203. The net change in allowance during the quarter ended January 31, 2014 was $64,711. The Company had net operating losses (NOLs) as of January 31, 2014 of approximately $8,380,000 for federal tax purposes, portions of which are currently expiring each year through 2034. The Company may be able to utilize its NOLs to reduce future federal and state income tax liabilities. However, these NOLs are subject to various limitations under Internal Revenue Code (“IRC”) Section 382. IRC Section 382 limits the use of NOLs to the extent there has been an ownership change of more than 50 percentage points. In addition, the NOL carry-forwards are subject to examination by the taxing authority and could be adjusted or disallowed due to such exams. Although the Company has not undergone an IRC Section 382 analysis, it is possible that the utilization of the NOLs could be substantially limited. The Company has no tax provision for the quarterly periods ended January 31, 2014 and 2013 due to losses and full valuation allowances against net deferred tax assets. As of January 31 2014, the difference between the tax provision at the statutory federal income tax rate and the tax provision attributable to loss before income taxes is as follows (in percentages): Statutory federal income tax rate (34 )% State taxes – net of federal benefits (5 )% Valuation allowance 39 % Income tax rate – net 0 % Fin 48 - Accounting for Uncertain Tax Positions The Company files income tax returns in the U.S. federal jurisdiction and various state, and local jurisdictions. The Company is no longer subject to U.S. federal income tax examination by tax authorities for the years prior to October 31, 2005. With respect to state and local jurisdictions, with limited exception, the Company and or its subsidiaries are no longer subject to income tax audits prior to October 31, 2005. In the normal course of business, the Company is subject to examination by various taxing authorities. Although the outcome of tax audits is always uncertain, the Company believes that adequate amounts of tax, interest and penalties have been provided for any adjustments that may result from these open tax years. Based on management’s review of the Company’s tax position, the Company and subsidiaries had no significant unrecognized corporate tax liabilities as of January 31, 2014 and 2013 payable to the Internal Revenue Service due to the net operating loss carry-forward, however, the Company had yet to file its 2005 through 2009 Federal, New Jersey nor New York Corporate Income Tax Returns.

UNPAID PAYROLL TAXES

UNPAID PAYROLL TAXES	3 Months Ended
	Jan. 31, 2014
UNPAID PAYROLL TAXES
NOTE 9. UNPAID PAYROLL TAXES	As of January 31, 2014, the Company owed the Internal Revenue Service and New York State payroll related taxes in the amounts of $135,875 and $30,084, respectively, plus applicable interest and penalties. The total amount due to both taxing authorities including penalties and interest was $165,959 as of January 31, 2014, and October 31, 2013, subject to further penalties and interest plus accruals on unpaid wages.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Jan. 31, 2014
COMMITMENTS AND CONTINGENCIES
NOTE 10. COMMITMENTS AND CONTINGENCIES	Rent As of January 31, 2014, the Company maintains its office in New York, New York. There is a month-to-month office lease. The rent is approximately $1,050 per month for our current office location. The Company rents its office space from the father of the Company’s President and Chief Executive Officer. For the three month periods ended January 31, 2014 and 2013, rent expense was $3,150 and is included within general and administrative expenses on the statements of operations. The total amount owed for accumulated rent as of January 31, 2014 and October 31, 2013, was $20,600 and $17,450, respectively, and is included within accounts payable on the balance sheet. As of January 31, 2014 and October 31, 2013, the total amount owed to related party was $39,800 and $36,650, including $20,600 and $17,450, respectively, for accumulated rent. IRS Tax Lien The Internal Revenue Service has placed a federal tax lien on all of the assets of the Company.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Jan. 31, 2014
SUBSEQUENT EVENTS
NOTE 11. SUBSEQUENT EVENTS	The Company has evaluated subsequent events for recognition and disclosure through January 29, 2021, the date the financial statements were available to be issued, and determined that there were no such events requiring adjustment to, or disclosure in, the accompanying financial statements, other than included below. Change of Domicile On November 3, 2017 the Company changed its domicile from New Jersey to Delaware and authorized shares to 20 Billion shares of common stock, par value, $0.000001 per share, and 500 Million shares of Series A Preferred Stock, par value, $0.000001 per share, and 500 Million Shares of Series B Preferred Stock, par value, $0.000001 per share. Each share of Series A and Series B Preferred Stock is convertible into 100 shares of the Company’s common stock. Release of Federal Tax Liens Between the period of May 2016 and April 2018 federal tax liens in the amount of $103,156 were released. D&E Agreements – Convertible Promissory Notes and Put Option Agreement On May 5, 2020, the Company entered into 4 agreements with D&E Holdings 20, LLC (“D&E”). The Agreements were: Convertible Promissory Note for $50,000 (the note has a 6-month term, a 10% interest rate and a conversion price of $0.0001), a Stock Purchase Agreement, a Note Purchase Agreement and a Put Option Agreement. The Put Option Agreement describes a transaction where, once D&E loans the Company a total of $100,000, then D&E may, at its sole discretion, exercise their Put Option to merge their real estate asset (a laboratory space consisting of between 30, 000 and 40,000 sq ft within the Former MetroSouth Medical Center Campus Illinois) with the Company. Upon D&E exercising the Put Option, D&E shall be issued a total of 83% of all of the outstanding shares of stock of the Company. Increase of Authorized Common and Preferred Shares. On December 21, 2020, the Company increased its authorized shares to 1 Trillion shares of common stock, par value, $0.000001 per share, and 5 Billion shares of Series A Preferred Stock, par value, $0.000001 per share, and 5 Billion Shares of Series B Preferred Stock, par value, $0.000001 per share. Each share of Series A and Series B Preferred Stock is convertible into 100 shares of the Company’s common stock. On December 31, 2020 the Company issued 1,050,000,000 common shares for services rendered to the Company. On December 31, 2020 five (5) Noteholders, including the Company’s Board of Director Members, converted a total of $1,965,460 of convertible promissory notes into 40,702,104,817 common shares of the Company. The Company’s two Board of Director Members converted a total of $1,644,825 of convertible promissory notes into a total of 34,267,187,500 common shares. The Company’s Board of Director Members control approximately 87.32% of the voting rights of the Company. The 3 (three) Noteholders converted a total of $325,666 of convertible promissory notes into a total of 6,434,917,317 common shares.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Jan. 31, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	The accompanying financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and reflect all adjustments, consisting of normal recurring adjustments, which management believes are necessary to fairly present the financial position, results of operations and cash flows of the Company as of and for the quarters ended January 31, 2014 and 2013.
Use of Estimates	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported revenues and expenses during the reporting periods. Because of the use of estimates inherent in the financial reporting process, actual results may differ significantly from those estimates.
Cash And Cash Equivalents	The Company maintains cash balances in a non-interest bearing account that currently does not exceed federally insured limits. For the purpose of the statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents. There were no cash equivalents as of January 31, 2014 and October 31, 2013.
Net Loss Per Share Calculation	Basic net loss per common share ("EPS") is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued.
Revenue Recognition and Sales Incentives	Sales will be recognized when an online or mobile transaction is processed, which occurs when a user of one of the Company’s software products purchases the products online or in an app. Sales are reported net of sales incentives, which could include discounts and promotions.
Income Taxes	The provision for income taxes is the total of the current taxes payable and the net of the change in the deferred income taxes. Provision is made for the deferred income taxes where differences exist between the period in which transactions affect current taxable income and the period in which they enter into the determination of net income in the financial statements.
Fair Value of Financial Instruments	Fresh Harvest’s financial instruments include cash and cash equivalents, accounts payable, accrued liabilities, and debt. The carrying value of these financial instruments is considered to be representative of their fair value due to the short maturity of these instruments. The carrying amount of the debt approximates fair value, because the interest rates on these instruments approximate the interest rate on debt with similar terms available to the Company. Fresh Harvest’s derivative liabilities were adjusted to fair market value at the end of each reporting period, using Level 3 inputs. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows: Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities. The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts payable, accrued expenses and interest, certain notes payable and notes payable – due to related parties, approximate their fair values because of the short maturity of these instruments. The Company accounts for its derivative liabilities, at fair value, on a recurring basis under Level 3 (See Note 6).
Embedded Conversion Features	The Company evaluates embedded conversion features within convertible debt under Accounting Standards Codification (“ASC”) 815 “Derivatives and Hedging” to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 “Debt with Conversion and Other Options” for consideration of any beneficial feature.
Derivative financial instruments	When the Company issues debt that contains a conversion feature, it first evaluates whether the conversion feature meets the requirements to be treated as a derivative: a) one or more underlying, typically the price of the Company's stock; b) one or more notional amounts or payment provisions or both, generally the number of shares upon conversion; c) no initial net investment, which typically excludes the amount borrowed; and d) net settlement provisions, which in the case of convertible debt generally means the stock received upon conversion can be readily sold for cash. There are certain scope exceptions from derivative treatment, but these typically exclude conversion features that provide for a variable number of shares. If the conversion feature within convertible debt meet the requirements to be treated as a derivative, Fresh Harvest estimates the fair value of the derivative liability using the Monte Carlo Simulation Model upon the date of issuance. If the fair value of the derivative liability is higher than the face value of the convertible debt, the excess is immediately recognized as interest expense. Otherwise, the fair value of the derivative liability is recorded as a liability with an offsetting amount recorded as a debt discount, which offsets the carrying amount of the debt. The derivative liability is revalued at the end of each reporting period and any change in fair value is recorded as a change in fair value in the statements of operations. The debt discount is amortized through interest expense over the life of the debt. Derivative instrument liabilities and the host debt agreement are classified on the balance sheets as current or non-current based on whether settlement of the derivative instrument could be required within twelve months of the balance sheet date. The accounting treatment of derivative financial instruments requires that the Company record the embedded conversion option and warrants at their fair values as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded as non-operating, non-cash income or expense for each reporting period at each balance sheet date. The Company reassesses the classification of its derivative instruments at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. As a result of entering into warrant agreements, for which such instruments contained a variable conversion feature with no floor, the Company has adopted a sequencing policy in accordance with ASC 815-40-35-12 “Derivatives and Hedging” (provides comprehensive guidance on derivative and hedging transactions) whereby all future instruments may be classified as a derivative liability with the exception of instruments related to share-based compensation issued to employees or directors.
Debt Issue Costs and Debt Discount	The Company may record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash, or equity (such as warrants). These costs are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed.
Share-based compensation	The Company accounts for common stock issued to employees, directors, and consultants in accordance with the provisions of the Accounting Standards Codification (ASC) 718 Stock Based Compensation
Recently Issued Accounting Pronouncements	As of and for the fiscal quarter ended January 31, 2014, the Company does not expect any of the recently issued accounting pronouncements to have a material impact on its financial condition or results of operations.
Subsequent Events	In accordance with ASC 855, Subsequent Events, the Company evaluated subsequent events through the date of this report; the date the financial statements were available for issue.

NOTES PAYABLE (Tables)

NOTES PAYABLE (Tables)	3 Months Ended
	Jan. 31, 2014
NOTES PAYABLE
Schedule of Notes Payable	Date of Note Issuance Original Principal Balance Maturity Date Interest Rate % Conversion Rate Principal Balance 1/31/14 Principal Balance 10/31/13 11/1/13 $ 50,000 11/1/14 10 % lesser $0.0003 or 50% discount to market $ 50,000 $ - 2/1/13 50,000 2/1/14 10 % lesser $0.0015 or 50% discount to market 50,000 50,000 10/31/12 104,278 10/31/13 10 % lesser $0.0015 or 50% discount to market 104,278 104,278 3/16/12 50,000 9/16/12 10 % $ 0.00200 60,000 60,000 2/14/12 14,900 2/14/13 10 % $ 0.00100 24,900 24,900 2/10/12 25,000 8/10/12 10 % $ 0.00119 25,000 25,000 1/26/12 40,000 7/26/12 10 % $ 0.00113 8,000 8,000 1/26/12 65,595 7/26/12 10 % $ 0.00113 27,595 27,595 10/18/11 1,900 10/18/11 8 % no written agreement 6,900 6,900 10/11/11 2,500 4/11/12 12 % $ 0.00390 2,500 2,500 8/25/11 108,101 2/25/12 10 % $ 0.01000 2,631 2,631 10/3/10 20,000 10/3/12 10 % lesser $0.01 or 20% discount to market 20,000 20,000 10/31/09 4,000 10/31/10 8 % no written agreement 4,000 4,000 8/31/09 5,000 8/31/12 12 % lesser $0.01 or 20% discount to market 5,000 5,000 8/26/09 20,000 8/26/12 12 % lesser $0.01 or 20% discount to market 20,000 20,000 8/25/09 20,000 8/25/12 12 % lesser $0.01 or 20% discount to market 20,000 20,000 2/26/07 30,000 2/26/09 12 % lesser $0.50 or 35% discount to market 30,000 30,000 4/17/07 20,000 4/17/09 10 % lesser $0.45 or 35% discount to market 20,000 20,000 6/14/07 15,000 6/15/09 10 % lesser $0.50 or 25% discount to market 15,000 15,000 1/29/07 15,000 1/29/09 10 % $ 0.95000 15,000 15,000 4/17/07 15,000 4/17/09 10 % lesser $0.45 or 35% discount to market 15,000 15,000 12/23/06 18,000 12/23/08 10 % $ 0.95000 18,000 18,000 11/30/06 50,000 11/30/08 10 % $ 0.85000 50,000 50,000 9/16/06 100,000 9/9/08 12 % 35% discount to market 38,000 38,000 10/1/05 15,000 4/1/07 10 % $ 0.50000 15,000 15,000 Total $ 646,804 $ 596,804 Debt Discount (47,215 ) (31,071 ) Total $ 599,589 $ 565,733

DERIVATIVE LIABILITY (Tables)

DERIVATIVE LIABILITY (Tables)	3 Months Ended
	Jan. 31, 2014
DERIVATIVE LIABILITY
Schedule of Fair value derivative liabilities	January 31, 2014 Indexed Fair The financings giving rise to derivative financial instruments Shares Values Compound embedded derivative 2,978,951,043 $ (515,733 ) October 31, 2013 Indexed Fair The financings giving rise to derivative financial instruments Shares Values Compound embedded derivative 2,549,713,618 $ (435,515 )
Schedule of derivative financial instruments	Three Months Ended January 31, 2014 January 31, 2013 Compound embedded derivative $ (21,551 ) $ 61,697 Day one derivative loss (8,667 ) - Total derivative gain (loss) $ (30,218 ) $ 61,697
Schedule of Convertible Notes	January 31, 2014 January 31, 2013 Quoted market price on valuation date $ 0.0003 $ 0.0002 Contractual conversion rate $ 0.00011 - $0.00023 $ 0.0009 - $0.00015 Range of effective contractual conversion rates -- -- Contractual term to maturity 0.25 Years 1.00 Year Market volatility: Volatility 138.28% - 238.13 % 138.28% - 238.13 % Contractual interest rate 5% - 12 % 5% - 12 %
Schedule of compound embedded derivatives	January 31, 2014 October 31, 2013 Beginning balance $ 435,515 $ 334,526 Issuances: Convertible Note Financing 50,000 50,000 Changes in fair value inputs and assumptions reflected in income 30,218 50,989 Ending balance $ 515,733 $ 435,515

PROVISION FOR CORPORATE INCOM_2

PROVISION FOR CORPORATE INCOME TAXES (Tables)	3 Months Ended
	Jan. 31, 2014
PROVISION FOR CORPORATE INCOME TAXES
Schedule of statutory federal income tax rate	Statutory federal income tax rate (34 )% State taxes – net of federal benefits (5 )% Valuation allowance 39 % Income tax rate – net 0 %

LIQUIDITY, CAPITAL RESOURCES _2

LIQUIDITY, CAPITAL RESOURCES AND GOING CONCERN (Details Narrative) - USD ($)	3 Months Ended
	Jan. 31, 2014	Jan. 31, 2013	Oct. 31, 2013
LIQUIDITY, CAPITAL RESOURCES AND GOING CONCERN
Total assets	$ 0		$ 0
Total liabilities	2,857,201		2,666,876
Accumulated deficit	(10,075,369)		$ (9,885,044)
Net loss	$ (190,325)	$ (197,438)

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	Jan. 31, 2014	Jan. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Cash and cash equivalents	$ 0	$ 0

NOTES PAYABLE - RELATED PARTI_2

NOTES PAYABLE - RELATED PARTIES (Details Narrative) - USD ($)	3 Months Ended
	Jan. 31, 2014	Oct. 31, 2013
NOTES PAYABLE - RELATED PARTIES
Convertible price	$ 0.0001
Notes payable, related party, current	$ 32,312	$ 32,312
Interest payable	$ 4,119	$ 3,231
Interest rate	10.00%
Debt term	1 year

NOTES PAYABLE (Details)

NOTES PAYABLE (Details) - USD ($)	3 Months Ended
	Jan. 31, 2014	Jan. 31, 2013
Notes payable	$ 646,804	$ 596,804
Debt discount	(47,215)	(31,071)
Total Notes payable	$ 599,589	565,733
Interest rate	10.00%
Notes Payable Twenty Five[Member]
Date of issuance	Oct. 1, 2005
Maturity date	Apr. 1, 2007
Interest rate	10.00%
Conversion rate	$ 0.50000
Debt instrument, principal balance	$ 15,000	15,000
Debt instrument, original principal balance	$ 15,000
Notes Payable Twenty Four [Member]
Date of issuance	Sep. 16, 2006
Maturity date	Sep. 9, 2008
Interest rate	12.00%
Debt instrument, principal balance	$ 38,000	38,000
Debt instrument, original principal balance	$ 100,000
Conversion rate, percentage	35.00%
Notes Payable Twenty Three [Member]
Date of issuance	Nov. 30, 2006
Maturity date	Nov. 30, 2008
Interest rate	10.00%
Conversion rate	$ 0.85000
Debt instrument, principal balance	$ 50,000	50,000
Debt instrument, original principal balance	$ 50,000
Notes Payable Twenty Two [Member]
Date of issuance	Dec. 23, 2006
Maturity date	Dec. 23, 2008
Interest rate	10.00%
Conversion rate	$ 0.95000
Debt instrument, principal balance	$ 18,000	18,000
Debt instrument, original principal balance	$ 18,000
Notes Payable Twenty One [Member]
Date of issuance	Apr. 17, 2007
Maturity date	Apr. 17, 2009
Interest rate	10.00%
Conversion rate	$ 0.45
Debt instrument, principal balance	$ 15,000	15,000
Debt instrument, original principal balance	$ 15,000
Conversion rate, percentage	35.00%
Notes Payable Twenty [Member]
Date of issuance	Jan. 29, 2007
Maturity date	Jan. 29, 2009
Interest rate	10.00%
Conversion rate	$ 0.95000
Debt instrument, principal balance	$ 15,000	15,000
Debt instrument, original principal balance	$ 15,000
Notes Payable Nineteen [Member]
Date of issuance	Jun. 14, 2007
Maturity date	Jun. 15, 2009
Interest rate	10.00%
Conversion rate	$ 0.50
Debt instrument, principal balance	$ 15,000	15,000
Debt instrument, original principal balance	$ 15,000
Conversion rate, percentage	25.00%
Notes Payable Eighteen [Member]
Date of issuance	Apr. 17, 2007
Maturity date	Apr. 17, 2009
Interest rate	10.00%
Conversion rate	$ 0.45
Debt instrument, principal balance	$ 20,000	20,000
Debt instrument, original principal balance	$ 20,000
Conversion rate, percentage	35.00%
Notes Payable Seventeen [Member]
Date of issuance	Feb. 26, 2007
Maturity date	Feb. 26, 2009
Interest rate	12.00%
Conversion rate	$ 0.50
Debt instrument, principal balance	$ 30,000	30,000
Debt instrument, original principal balance	$ 30,000
Conversion rate, percentage	35.00%
Notes Payable Sixteen [Member]
Date of issuance	Aug. 25, 2009
Maturity date	Aug. 25, 2012
Interest rate	12.00%
Conversion rate	$ 0.01
Debt instrument, principal balance	$ 20,000	20,000
Debt instrument, original principal balance	$ 20,000
Conversion rate, percentage	20.00%
Notes Payable Fifteen [Member]
Date of issuance	Aug. 26, 2009
Maturity date	Aug. 26, 2012
Interest rate	12.00%
Conversion rate	$ 0.01
Debt instrument, principal balance	$ 20,000	20,000
Debt instrument, original principal balance	$ 20,000
Conversion rate, percentage	20.00%
Notes Payable Fourteen [Member]
Date of issuance	Aug. 31, 2009
Maturity date	Aug. 31, 2012
Interest rate	12.00%
Conversion rate	$ 0.01
Debt instrument, principal balance	$ 5,000	5,000
Debt instrument, original principal balance	$ 5,000
Conversion rate, percentage	20.00%
Notes Payable Thirteen [Member]
Date of issuance	Oct. 31, 2009
Maturity date	Oct. 31, 2010
Interest rate	8.00%
Debt instrument, principal balance	$ 4,000	4,000
Debt instrument, original principal balance	$ 4,000
Conversion rate descriptions	no written agreement
Notes Payable Twelve [Member]
Date of issuance	Oct. 3, 2010
Maturity date	Oct. 3, 2012
Interest rate	10.00%
Conversion rate	$ 0.01
Debt instrument, principal balance	$ 20,000	20,000
Debt instrument, original principal balance	$ 20,000
Conversion rate, percentage	20.00%
Notes Payable Eleven [Member]
Date of issuance	Aug. 25, 2011
Maturity date	Feb. 25, 2012
Interest rate	10.00%
Conversion rate	$ 0.01000
Debt instrument, principal balance	$ 2,631	2,631
Debt instrument, original principal balance	$ 108,101
Notes Payable Ten [Member]
Date of issuance	Oct. 11, 2011
Maturity date	Apr. 11, 2012
Interest rate	12.00%
Conversion rate	$ 0.00390
Debt instrument, principal balance	$ 2,500	2,500
Debt instrument, original principal balance	$ 2,500
Notes Payable Nine [Member]
Date of issuance	Oct. 18, 2011
Maturity date	Oct. 18, 2011
Interest rate	8.00%
Debt instrument, principal balance	$ 6,900	6,900
Debt instrument, original principal balance	$ 1,900
Conversion rate descriptions	no written agreement
Notes Payable Eight [Member]
Date of issuance	Jan. 26, 2012
Maturity date	Jul. 26, 2012
Interest rate	10.00%
Conversion rate	$ 0.00113
Debt instrument, principal balance	$ 27,595	27,595
Debt instrument, original principal balance	$ 65,595
Notes Payable Seven [Member]
Date of issuance	Jan. 26, 2012
Maturity date	Jul. 26, 2012
Interest rate	10.00%
Conversion rate	$ 0.00113
Debt instrument, principal balance	$ 8,000	8,000
Debt instrument, original principal balance	$ 40,000
Notes Payable Six [Member]
Date of issuance	Feb. 10, 2012
Maturity date	Aug. 10, 2012
Interest rate	10.00%
Conversion rate	$ 0.00119
Debt instrument, principal balance	$ 25,000	25,000
Debt instrument, original principal balance	$ 25,000
Notes Payable Five [Member]
Date of issuance	Feb. 14, 2012
Maturity date	Feb. 14, 2013
Interest rate	10.00%
Conversion rate	$ 0.00100
Debt instrument, principal balance	$ 24,900	24,900
Debt instrument, original principal balance	$ 14,900
Notes Payable Four [Member]
Date of issuance	Mar. 16, 2012
Maturity date	Sep. 16, 2012
Interest rate	10.00%
Conversion rate	$ 0.00200
Debt instrument, principal balance	$ 60,000	60,000
Debt instrument, original principal balance	$ 50,000
Notes Payable Three [Member]
Date of issuance	Oct. 31, 2012
Maturity date	Oct. 31, 2013
Interest rate	10.00%
Conversion rate	$ 0.0015
Debt instrument, principal balance	$ 104,278	104,278
Debt instrument, original principal balance	$ 104,278
Conversion rate, percentage	50.00%
Notes Payable Two [Member]
Date of issuance	Feb. 1, 2013
Maturity date	Feb. 1, 2014
Interest rate	10.00%
Conversion rate	$ 0.0015
Debt instrument, principal balance	$ 50,000	50,000
Debt instrument, original principal balance	$ 50,000
Conversion rate, percentage	50.00%
Notes Payable One [Member]
Date of issuance	Nov. 1, 2013
Maturity date	Nov. 1, 2014
Interest rate	10.00%
Conversion rate	$ 0.0003
Debt instrument, principal balance	$ 50,000	$ 0
Debt instrument, original principal balance	$ 50,000
Conversion rate, percentage	50.00%

DERIVATIVE LIABILITY (Details)

DERIVATIVE LIABILITY (Details) - Compound embedded derivative [Member] - USD ($)	Jan. 31, 2014	Oct. 31, 2013
Indexed Shares	2,978,951,043	2,549,713,618
Fair Value	$ (515,733)	$ (435,515)

DERIVATIVE LIABILITY (Details 1

DERIVATIVE LIABILITY (Details 1) - USD ($)	3 Months Ended
	Jan. 31, 2014	Jan. 31, 2013
DERIVATIVE LIABILITY
Compound embedded derivative	$ (21,551)	$ 61,697
Day one derivative loss	(8,667)	0
Total derivative gain (loss)	$ 80,218	$ 61,697

DERIVATIVE LIABILITY (Details 2

DERIVATIVE LIABILITY (Details 2) - $ / shares	3 Months Ended
	Jan. 31, 2014	Jan. 31, 2013
Quoted market price on valuation date	$ 0.0003	$ 0.0002
Range of effective contractual conversion rates	0.00%	0.00%
Contractual term to maturity	2 months 30 days	1 year
Contractual interest rate	10.00%
Minimum [Member]
Contractual interest rate	5.00%	5.00%
Contractual conversion rate	$ 0.00011	$ 0.0009
Market volatility:	138.28%	138.28%
Maximum [Member]
Contractual interest rate	12.00%	12.00%
Contractual conversion rate	$ 0.00023	$ 0.00015
Market volatility:	238.13%	238.13%

DERIVATIVE LIABILITY (Details 3

DERIVATIVE LIABILITY (Details 3) - USD ($)	3 Months Ended	12 Months Ended
	Jan. 31, 2014	Oct. 31, 2013
DERIVATIVE LIABILITY
Beginning balance	$ 435,515	$ 334,527
Issuances Convertible Note Financing	50,000	50,000
Changes in fair value inputs and assumptions reflected in income	30,218	50,989
Ending balance	$ 515,733	$ 435,515

STOCKHOLDERS EQUITY (Details Na

STOCKHOLDERS EQUITY (Details Narrative) - $ / shares	1 Months Ended	3 Months Ended
	Feb. 23, 2011	Jan. 31, 2014
STOCKHOLDERS EQUITY
Series A Convertible Preferred Stock par share	$ 0.0001
Series A convertible preferred stock conversion description		Each share of Series A Preferred Stock is generally convertible into 100 shares of the Company’s common stock (the “Conversion Rate”).
Series A Convertible Preferred Stock Shares	5,000,000

PROVISION FOR CORPORATE INCOM_3

PROVISION FOR CORPORATE INCOME TAXES (Details)	3 Months Ended
	Jan. 31, 2014
PROVISION FOR CORPORATE INCOME TAXES (Details)
Statutory federal income tax rate	(34.00%)
State taxes - net of federal benefits	(5.00%)
Valuation allowance	39.00%
Income tax rate - net	0.00%

PROVISION FOR CORPORATE INCOM_4

PROVISION FOR CORPORATE INCOME TAXES (Details Narrative)	3 Months Ended
	Jan. 31, 2014USD ($)
PROVISION FOR CORPORATE INCOME TAXES (Details)
Net change in allowance	$ 64,711
valuation allowance	2,850,203
Net operating loss carryforward	$ 8,380,000

UNPAID PAYROLL TAXES (Details N

UNPAID PAYROLL TAXES (Details Narrative) - USD ($)	Jan. 31, 2014	Oct. 31, 2013
STOCKHOLDERS EQUITY
Payroll related taxes, Internal Revenue Service	$ 135,875
Payroll related taxes, New York State	30,084
Due to IRS and New York State payroll taxes	$ 165,959	$ 165,959

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	3 Months Ended
	Jan. 31, 2014	Jan. 31, 2013
Office lease rent per month	$ 1,050
Due to related party	39,800	$ 36,650
Rent expense	3,150	3,150
Accumulated rent	20,600	17,450
Related Party [Member]
Accumulated rent	$ 20,600	$ 17,450

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	May 05, 2020	Nov. 03, 2017	Dec. 31, 2020	Jan. 31, 2014	Apr. 30, 2018	Dec. 21, 2020	Oct. 31, 2013
Common Stock, Shares Authorized		20,000,000,000		2,000,000,000			2,000,000,000
Common Stock, Par value		$ 0.000001		$ .0001			$ .0001
Convertible price				$ 0.0001
Debt term				1 year
Series A convertible preferred stock conversion description				Each share of Series A Preferred Stock is generally convertible into 100 shares of the Company’s common stock (the “Conversion Rate”).
Preferred Stock, Shares Authorized				5,000,000			5,000,000
Preferred Stock, Par Value				$ .0001			$ .0001
Subsequent Event [Member]
Common Stock, Shares Authorized						1,000,000,000,000
Common Stock, Par value						$ 0.000001
Debt conversion, converted amount			$ 1,965,460
Debt conversion, converted instrument, shares			40,702,104,817
Common stock, shares issued for services rendered			1,050,000,000
Series A convertible preferred stock conversion description		Each share of Series A and Series B Preferred Stock is convertible into 100 shares of the Company’s common stock.
Subsequent Event [Member] | Series B Preferred Stock [Member]
Preferred Stock, Shares Authorized		500,000,000				5,000,000,000
Preferred Stock, Par Value		$ 0.000001				$ 0.000001
Subsequent Event [Member] | Series A Preferred Stock [Member]
Preferred Stock, Shares Authorized		500,000,000				5,000,000,000
Preferred Stock, Par Value		$ 0.000001				$ 0.000001
Subsequent Event [Member] | D&E Holdings 20, LLC [Member]
Fedral tax amount					$ 103,156
Convertible price	$ 0.0001
Interest rate	10.00%
Loans payable	$ 100,000
Debt description	At its sole discretion, exercise their Put Option to merge their real estate asset (a laboratory space consisting of between 30, 000 and 40,000 sq ft within the Former MetroSouth Medical Center Campus Illinois) with the Company. Upon D&E exercising the Put Option, D&E shall be issued a total of 83% of all of the outstanding shares of stock of the Company.
Convertible Promissory Note	$ 50,000
Debt term	6 months
Subsequent Event [Member] | Three Noteholders [Member]
Debt conversion, converted amount			$ 325,666
Ownership percentage			87.32%
Debt conversion, converted instrument, shares			6,434,917,317
Subsequent Event [Member] | Two Director [Member]
Debt conversion, converted amount			$ 1,644,825
Debt conversion, converted instrument, shares			34,267,187,500